NGD (NGD)

$7.2B
Market Cap
28.4
P/E Ratio
1.83
Beta
Dividend Yield
Piotroski 7/9Altman Z 4.3 SafeBeneish M -2.32 CleanROIC−WACC +11.7%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 4.3 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of NGD demonstrate a robust capital allocation efficiency, evidenced by an ROIC-WACC spread of +11.7%, indicating the company generates returns significantly exceeding its cost of capital. This high-quality profile is further reinforced by a Piotroski F-Score of 7/9 and a Beneish M-Score of -2.32, suggesting strong financial health with minimal earnings manipulation risk. The DuPont decomposition reveals that this performance is driven primarily by exceptional profitability rather than leverage or asset turnover; specifically, net margins at 58.1% and gross margins of 53.2% are the primary engines fueling an ROE well above industry norms. Additionally, revenue growth accelerating to 59.7% YoY aligns with these margin expansions, creating a compounding value creation scenario typical of high-conviction small-cap opportunities.

Despite the superior operational metrics, valuation multiples present a divergence from intrinsic worth. The current P/E ratio stands at 28.4x, which appears elevated relative to the underlying cash flow generation implied by the DCF analysis showing a fair value of $7. This discrepancy suggests the market is pricing in aggressive future growth assumptions that may not be fully supported by historical trajectory or conservative terminal values. While the high margin environment allows for significant earnings leverage, the current multiple leaves little room for error if revenue expansion moderates from its recent 59.7% pace, potentially compressing returns over the medium term as expectations normalize around a more sustainable growth rate.

The risk profile appears mitigated by an Altman Z-Score of 4.3, which places the firm in a "safe zone" with low bankruptcy probability, yet the gap between current market pricing and DCF-derived fair value introduces downside volatility if macroeconomic headwinds impact high-margin operations. Without specific sector peer data or insider transaction records to contextualize the premium valuation, investors must weigh whether the 28.4x multiple adequately compensates for the uncertainty surrounding long-term growth sustainability versus the safety provided by strong balance sheet metrics and clean earnings quality indicators.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →13.4%15.4%17.4%
2%$8$7$6
3%$9$7$6
4%$10$8$6

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=15.3%, terminal growth 3%. Fair value $7 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
4.3
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.32
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

53.2%
Gross Margin
58.1%
Net Margin
27.0%
ROIC
15.3%
WACC
ROIC − WACC Spread: +11.7%— Positive value creation spread.
+59.7%
Revenue Growth (YoY)
+736.2%
Earnings Growth (YoY)
305.3M
Free Cash Flow

Balance Sheet Health

0.66x
Debt / Equity
1.32x
Current Ratio
26.6x
Interest Coverage
0.1x
Net Debt / EBITDA
4.19%
FCF Yield
1.2B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.02
Act: $0.02
+25.0%
Q3
✓ Beat
Est: $0.10
Act: $0.11
+8.8%
Q2
✓ Beat
Est: $0.18
Act: $0.25
+37.2%
Q1
✓ Beat
Est: $0.23
Act: $0.33
+41.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

7.7
Forward P/E
PEG Ratio
5.80
Price/Book
18M
Avg Volume
$13.63
52W High
$2.90
52W Low
52W Range Position

NGD Capital Efficiency

How efficiently does NGD convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$305M
EBITDA
$1.2B
FCF Conversion
26%
Reinvestment Rate
74%
26% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
27.0%
ROIC − WACC Spread
11.7%

NGD converts 26% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 74% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 11.7% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-03-20691$9.08$6,274.28
2026-03-174,169$10.32$43,024.08
2026-03-13325,074$10.72$3.5M
2026-03-12452$11.05$4,994.6
2026-03-109,444$11.17$105,489.48
2026-03-042,675$11.91$31,859.25
2026-03-0356,817$13.33$757,370.61
2026-03-021,860$13.42$24,961.2
2026-02-265,194$12.19$63,314.86
2026-02-255,314$12.25$65,096.5
2026-02-2348,800$12.22$596,336
2026-02-192,831$11.22$31,763.82
2026-02-18200$10.77$2,154
2026-02-1754,373$11.06$601,365.38
2026-02-13900$10.33$9,297
2026-02-1170$11.32$792.4
2026-02-0410$10.49$104.9
2026-02-0253,276$10.03$534,358.28
2026-01-29989,222$12.57$12.4M
2026-01-28100$12.58$1,258
2026-01-2720,833$12.50$260,412.5
2026-01-2392,821$12.62$1.2M
2026-01-2040,780$11.06$451,026.8
2026-01-1333,636$10.55$354,859.8
2026-01-091,727$9.56$16,510.12
2026-01-08537$9.36$5,026.32
2026-01-0737$9.52$352.24
2026-01-0219,000$8.71$165,490
2025-12-3119,165$8.81$168,843.65
2025-12-306,131$8.89$54,504.59

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare NGD to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.